Omada Health, Inc. (OMDA) Price & Analysis

Compare

150 Followers

OMDA Stock Chart & Stats

$16.44

-$4.40(-19.47%)

At close: Jun 10 4:00 PM EDT

$16.44

-$4.40(-19.47%)

Day’s Range― - ―

52-Week Range$14.14 - $28.40

Previous Close$18.29

Volume2.54M

Average Volume (3M)1.09M

Market Cap

$959.54M

Enterprise Value$1.08B

Total Cash (Recent Filing)$198.63M

Total Debt (Recent Filing)$0.00

Price to Earnings (P/E)―

Beta3.05

Next Earnings

Aug 06, 2026

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)-0.06

Shares Outstanding57,908,047

10 Day Avg. Volume783,248

30 Day Avg. Volume1,090,574

Financial Highlights & Ratios

PEG Ratio0.91

Price to Book (P/B)19.84

Price to Sales (P/S)7.55

P/FCF Ratio-33.70

Enterprise Value/Market Cap1.13

Enterprise Value/Revenue5.86

Enterprise Value/Gross Profit9.23

Enterprise Value/Ebitda-92.22

Forecast

1Y Price Target

$27.00

Price Target Upside64.23% Upside

Rating ConsensusStrong Buy

Number of Analyst Covering9

EPS Forecast (FY)-0.04

Revenue Forecast (FY)$310.64M

Bulls Say, Bears Say

Bulls Say

App DownloadsOmada app downloads increased 81% Y/Y in Q3, the second highest in history, which highlights a widening of Omada's lead over competitors.

Market PositionOmada has positioned itself to be a leader in a rapidly changing chronic care and GLP-1 landscape.

Revenue GrowthA large under-penetrated TAM, recent roll-out of an enhanced GLP-1 companion program, AI investments, and increasing cross-selling momentum provides significant runway for continued 20%+ revenue growth and expanding margins.

Bears Say

Omada Health, Inc. News

Omada Health price target lowered to $29 from $33 at Goldman Sachs

Goldman Sachs lowered the firm’s price target on Omada Health (OMDA) to $29 from $33 and keeps a...

1d ago

OMDA

Omada Health initiated with an Equal Weight at Wells Fargo

Wells Fargo initiated coverage of Omada Health (OMDA) with an Equal Weight rating and $17 price target The...

2d ago

OMDA

Omada announces results from 12-month analysis of GLP-1 companion program

Omada Health (OMDA) announced results from a 12-month real-world analysis of members in its GLP-1 companion program. By...

2d ago

OMDA

Omada Health price target lowered to $22 from $29 at Barclays

Barclays analyst Saket Kalia lowered the firm’s price target on Omada Health (OMDA) to $22 from $29 and...

5d ago

OMDA

Omada Health named Top Pick in Healthcare Technology at Morgan Stanley

Morgan Stanley named Omada Health (OMDA) as the firm’s Top Pick in Healthcare Technology with an Overweight rating...

23d ago

OMDA

Omada Health’s Strategic Growth and Profitability: A Buy Rating by Craig Hettenbach

Craig Hettenbach, an analyst from Morgan Stanley, maintained the Buy rating on Omada Health, Inc.. The associated price...

2M ago

OMDA

Omada Health Positioned for Growth with Strong Financial Performance and Strategic Market Opportunities

Omada Health, Inc. (OMDA) has received a new Buy rating, initiated by BMO Capital analyst, . BMO Capital’s...

2M ago

OMDA

Omada Health initiated with an Outperform at BMO Capital

BMO Capital initiated coverage of Omada Health (OMDA) with an Outperform rating and $27 price target A large...

2M ago

OMDA

Omada Health Reports Strong Growth and Innovation

Omada Health, Inc. (($OMDA)) has held its Q3 earnings call. Read on for the main highlights of the...

2M ago

OMDA

Omada Health price target raised to $32 from $30 at Morgan Stanley

Morgan Stanley raised the firm’s price target on Omada Health (OMDA) to $32 from $30 and keeps an...

2M ago

OMDA

Omada Health price target raised to $28 from $27 at Evercore ISI

Evercore ISI raised the firm’s price target on Omada Health (OMDA) to $28 from $27 and keeps an...

2M ago

OMDA

Omada Health, Inc.: Strong Revenue Momentum and Strategic Partnerships Drive Buy Rating

Analyst Richard Close of Canaccord Genuity maintained a Buy rating on Omada Health, Inc., with a price target...

2M ago

OMDA

Omada Health, Inc.: Strong Market Position and Growth Potential Drive Buy Rating

Ryan MacDonald, an analyst from Needham, reiterated the Buy rating on Omada Health, Inc.. The associated price target...

2M ago

OMDA

Omada Health price target raised to $29 from $28 at Barclays

Barclays analyst Saket Kalia raised the firm’s price target on Omada Health (OMDA) to $29 from $28 and...

2M ago

OMDA

OMDA FAQ

What was Omada Health, Inc.’s price range in the past 12 months?

Omada Health, Inc. lowest stock price was $14.14 and its highest was $28.40 in the past 12 months.

What is Omada Health, Inc.’s market cap?

Omada Health, Inc.’s market cap is $959.54M.

When is Omada Health, Inc.’s upcoming earnings report date?

Omada Health, Inc.’s upcoming earnings report date is Aug 06, 2026 which is in 208 days.

How were Omada Health, Inc.’s earnings last quarter?

Omada Health, Inc. released its earnings results on Nov 06, 2025. The company reported -$0.06 earnings per share for the quarter, beating the consensus estimate of -$0.079 by $0.019.

Is Omada Health, Inc. overvalued?

According to Wall Street analysts Omada Health, Inc.’s price is currently Undervalued. Get more investment ideas with TipRanks Premium

Does Omada Health, Inc. pay dividends?

Omada Health, Inc. does not currently pay dividends.

What is Omada Health, Inc.’s EPS estimate?

Omada Health, Inc.’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Omada Health, Inc. have?

Omada Health, Inc. has 57,908,047 shares outstanding.

What happened to Omada Health, Inc.’s price movement after its last earnings report?

Omada Health, Inc. reported an EPS of -$0.06 in its last earnings report, beating expectations of -$0.079. Following the earnings report the stock price went down -7.133%.

Which hedge fund is a major shareholder of Omada Health, Inc.?

Currently, no hedge funds are holding shares in OMDA

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Omada Health, Inc. Stock Smart Score

Outperform

Company Description

Omada Health, Inc.

Omada Health is a U.S.-based virtual-care provider offering clinically validated programs for chronic conditions like cardiometabolic disease, musculoskeletal care, and behavioral health—delivered digitally between doctor visits.

Omada Health, Inc. (OMDA) Earnings & Revenues

Historic Earnings Reports

OMDA Company Deck

OMDA Earnings Call

Q3 2025

0:00 / 0:00

Earnings Call Sentiment|Positive

The earnings call reflects strong growth in membership and revenue, driven by innovation and operational efficiency. Despite some concerns about cash flow due to debt repayment and reliance on the GLP-1 market segment, the overall financial and strategic outlook remains positive.View all OMDA earnings summaries

OMDA Stock 12 Month Forecast

Average Price Target

$27.00

▲(64.23% Upside)

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"14":"$14","33":"$33","18.75":"$18.75","23.5":"$23.5","28.25":"$28.3"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":32,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$32.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":27,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$27.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":17,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$17.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[14,18.75,23.5,28.25,33],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"May<br/>2025","6":"Jul<br/>2025","9":"Oct<br/>2025","12":"Jan<br/>2026","25":"Jan<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,15.78,17.027692307692305,18.275384615384613,19.52307692307692,20.77076923076923,22.018461538461537,23.266153846153845,24.513846153846153,25.76153846153846,27.00923076923077,28.256923076923076,29.504615384615384,30.75230769230769,{"y":32,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,15.78,16.643076923076922,17.506153846153847,18.369230769230768,19.232307692307693,20.095384615384614,20.95846153846154,21.82153846153846,22.684615384615384,23.54769230769231,24.41076923076923,25.27384615384615,26.136923076923075,{"y":27,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,15.78,15.873846153846154,15.967692307692307,16.06153846153846,16.155384615384616,16.24923076923077,16.34307692307692,16.436923076923076,16.53076923076923,16.624615384615385,16.71846153846154,16.81230769230769,16.906153846153845,{"y":17,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":22.6,"date":1738368000000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":22.6,"date":1740787200000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":22.6,"date":1743465600000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":22.6,"date":1746057600000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":22.6,"date":1748736000000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":22.6,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":18.25,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":17.38,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 17,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":23.77,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 16,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":22.42,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":24.57,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 14,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":18.73,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":15.78,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Detailed Analyst Forecast >